Aggregate package
top120-public-preview-v0.1.1
- Status
- public preview aggregate; review gates passed
- Scope
- 12 diseases, 1,440 associations, 1,505 evidence rows
- Boundary
- research use only
120-association public preview
Gene-Disease Evidence Index
A versioned research-use index of source-attributed gene-disease evidence. This preview renders 12 disease-scoped releases, each containing up to 120 source-attributed associations, with a public aggregate package and fixed raw-data tag.
Research use only. This page is not medical advice, diagnosis, treatment
guidance, patient risk prediction, clinical decision support, or a claim of
clinical certainty.
1138 unique genes
1440 associations
1505 evidence rows
12 diseases
Looking for release packages? Jump to Releases.
Associations
Review labels describe automated gate artifacts only unless explicitly marked as human scientific review. The table contains only genes included in this fixed 120-association preview scope; absence from this page is not evidence of absence.
1440 associations
| Gene | Disease | Tier | Review | Sources | Evidence | Open Targets |
|---|---|---|---|---|---|---|
| SCN1A HGNC:10585 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.926 |
| CFTR HGNC:1884 | Cystic fibrosis | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.913 |
| MYH7 HGNC:7577 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.908 |
| BRAF HGNC:1097 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.907 |
| SCN2A HGNC:10588 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.903 |
| SCN8A HGNC:10596 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.902 |
| LMNA HGNC:6636 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.902 |
| KRAS HGNC:6407 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.899 |
| SCN3A HGNC:10590 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.898 |
| MYBPC3 HGNC:7551 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.895 |
| PTPN11 HGNC:9644 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.895 |
| TTN HGNC:12403 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.893 |
| RAF1 HGNC:9829 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.893 |
| BRCA2 HGNC:1101 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.892 |
| SOD1 HGNC:11179 | Amyotrophic lateral sclerosis | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.890 |
| HRAS HGNC:5173 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.888 |
| GABRB3 HGNC:4083 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.886 |
| GABRA1 HGNC:4075 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.886 |
| GABRG2 HGNC:4087 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.886 |
| CACNA1A HGNC:1388 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.884 |
| SLC2A1 HGNC:11005 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.882 |
| DES HGNC:2770 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.882 |
| MAP2K1 HGNC:6840 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.881 |
| GRIN2A HGNC:4585 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.880 |
| LRRK2 HGNC:18618 | Parkinson disease | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.880 |
| ACADVL HGNC:92 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.879 |
| BRCA1 HGNC:1100 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.876 |
| SNCA HGNC:11138 | Parkinson disease | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.875 |
| NOD2 HGNC:5331 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.875 |
| NRAS HGNC:7989 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.873 |
| SOS1 HGNC:11187 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.871 |
| KCNT1 HGNC:18865 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.871 |
| MAP2K2 HGNC:6842 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.870 |
| APP HGNC:620 | Alzheimer disease | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.870 |
| PALB2 HGNC:26144 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.867 |
| PSEN1 HGNC:9508 | Alzheimer disease | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.866 |
| STXBP1 HGNC:11444 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.866 |
| KCNJ11 HGNC:6257 | Type 2 diabetes mellitus | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.865 |
| CDKL5 HGNC:11411 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.865 |
| PCDH19 HGNC:14270 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.865 |
| ABCC8 HGNC:59 | Type 2 diabetes mellitus | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.865 |
| DEPDC5 HGNC:18423 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.865 |
| GABRB2 HGNC:4082 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.865 |
| LZTR1 HGNC:6742 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.864 |
| ETFDH HGNC:3483 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.863 |
| RBM20 HGNC:27424 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.863 |
| TP53 HGNC:11998 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.861 |
| GCK HGNC:4195 | Type 2 diabetes mellitus | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.861 |
| CSTB HGNC:2482 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.861 |
| PINK1 HGNC:14581 | Parkinson disease | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.861 |
| KCNQ2 HGNC:6296 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.859 |
| WWOX HGNC:12799 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.859 |
| PRKN HGNC:8607 | Parkinson disease | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.857 |
| ATP13A2 HGNC:30213 | Parkinson disease | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.857 |
| TARDBP HGNC:11571 | Amyotrophic lateral sclerosis | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.855 |
| FLNC HGNC:3756 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.852 |
| NHLRC1 HGNC:21576 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.851 |
| BAG3 HGNC:939 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.850 |
| PIK3CA HGNC:8975 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.850 |
| ETFA HGNC:3481 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.850 |
| SHOC2 HGNC:15454 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.849 |
| PPARG HGNC:9236 | Type 2 diabetes mellitus | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.849 |
| MYH7 HGNC:7577 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.848 |
| TNNT2 HGNC:11949 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.847 |
| PRRT2 HGNC:30500 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.847 |
| ALDH7A1 HGNC:877 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.847 |
| FKTN HGNC:3622 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.846 |
| SRY HGNC:11311 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.846 |
| CACNA1E HGNC:1392 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.845 |
| FUS HGNC:4010 | Amyotrophic lateral sclerosis | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.845 |
| TBC1D24 HGNC:29203 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.844 |
| EPM2A HGNC:3413 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.844 |
| PGM1 HGNC:8905 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.844 |
| ETFB HGNC:3482 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.843 |
| RIT1 HGNC:10023 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.843 |
| SOS2 HGNC:11188 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.842 |
| TNNI3 HGNC:11947 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.842 |
| ZEB2 HGNC:14881 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.842 |
| MYBPC3 HGNC:7551 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.842 |
| MYL2 HGNC:7583 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.841 |
| CDKN1C HGNC:1786 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.840 |
| HADHA HGNC:4801 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.840 |
| CHEK2 HGNC:16627 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.840 |
| PPP1CB HGNC:9282 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.839 |
| ACTC1 HGNC:143 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.839 |
| SGCA HGNC:10805 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.838 |
| PRKAG2 HGNC:9386 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.838 |
| GNAO1 HGNC:4389 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.835 |
| KCNMA1 HGNC:6284 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.835 |
| ATM HGNC:795 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.835 |
| FHL1 HGNC:3702 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.832 |
| MYL3 HGNC:7584 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.831 |
| GABRB1 HGNC:4081 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.831 |
| CBL HGNC:1541 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.831 |
| IL10RA HGNC:5964 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.831 |
| TBK1 HGNC:11584 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.831 |
| LGI1 HGNC:6572 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.830 |
| ARX HGNC:18060 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.829 |
| FHOD3 HGNC:26178 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.828 |
| PIGA HGNC:8957 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.828 |
| SPRED1 HGNC:20249 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.827 |
| MYPN HGNC:23246 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.827 |
| RAD51C HGNC:9820 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.826 |
| KCTD7 HGNC:21957 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.826 |
| TNNI3 HGNC:11947 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.826 |
| DNAJC6 HGNC:15469 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.825 |
| DNM1 HGNC:2972 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.825 |
| PNKP HGNC:9154 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.823 |
| SQSTM1 HGNC:11280 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.823 |
| UBQLN2 HGNC:12509 | Amyotrophic lateral sclerosis | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.823 |
| CDH1 HGNC:1748 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.823 |
| SCN1B HGNC:10586 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.823 |
| RRAS2 HGNC:17271 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.823 |
| SYNGAP1 HGNC:11497 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.823 |
| ERBB2 HGNC:3430 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.822 |
| UBA5 HGNC:23230 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.822 |
| TPM1 HGNC:12010 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.821 |
| DOLK HGNC:23406 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.821 |
| SPTAN1 HGNC:11273 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.821 |
| GABRA2 HGNC:4076 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.820 |
| IL10RB HGNC:5965 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.820 |
| PARK7 HGNC:16369 | Parkinson disease | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.819 |
| VCP HGNC:12666 | Amyotrophic lateral sclerosis | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.818 |
| TAFAZZIN HGNC:11577 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.818 |
| PSEN2 HGNC:9509 | Alzheimer disease | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.817 |
| EMD HGNC:3331 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.816 |
| ESR1 HGNC:3467 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.816 |
| NR5A1 HGNC:7983 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.816 |
| CSRP3 HGNC:2472 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.816 |
| ALPK3 HGNC:17574 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.816 |
| SCN5A HGNC:10593 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.816 |
| SGCB HGNC:10806 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.816 |
| PPP3CA HGNC:9314 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.815 |
| MYH6 HGNC:7576 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.815 |
| VCL HGNC:12665 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.814 |
| AKT1 HGNC:391 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.813 |
| ACTN2 HGNC:164 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.813 |
| DMD HGNC:2928 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.813 |
| SZT2 HGNC:29040 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.813 |
| SLC12A5 HGNC:13818 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.813 |
| MYPN HGNC:23246 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.812 |
| GRIN2B HGNC:4586 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.812 |
| PLCB1 HGNC:15917 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.811 |
| PNPO HGNC:30260 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.811 |
| GRIN2D HGNC:4588 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.810 |
| SGCD HGNC:10807 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.810 |
| CHD2 HGNC:1917 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.810 |
| EEF1A2 HGNC:3192 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.809 |
| TNNC1 HGNC:11943 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.808 |
| GABRA5 HGNC:4079 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.808 |
| TUBA4A HGNC:12407 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.806 |
| SCN9A HGNC:10597 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.806 |
| SCARB2 HGNC:1665 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.806 |
| SGCG HGNC:10809 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.805 |
| FBXO7 HGNC:13586 | Parkinson disease | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.802 |
| ITPA HGNC:6176 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.801 |
| NPRL3 HGNC:14124 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.801 |
| CDK19 HGNC:19338 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.801 |
| ANG HGNC:483 | Amyotrophic lateral sclerosis | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.800 |
| ARHGEF9 HGNC:14561 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.800 |
| SLC25A22 HGNC:19954 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.800 |
| NEXN HGNC:29557 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.799 |
| CYFIP2 HGNC:13760 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.799 |
| MECP2 HGNC:6990 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.798 |
| SLC6A1 HGNC:11042 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.798 |
| JPH2 HGNC:14202 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.797 |
| RELN HGNC:9957 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.796 |
| KCNA2 HGNC:6220 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.796 |
| DCTN1 HGNC:2711 | Amyotrophic lateral sclerosis | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.795 |
| SETX HGNC:445 | Amyotrophic lateral sclerosis | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.795 |
| OPTN HGNC:17142 | Amyotrophic lateral sclerosis | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.794 |
| ATP6V1A HGNC:851 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.793 |
| KCNC2 HGNC:6234 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.793 |
| MDH2 HGNC:6971 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.793 |
| CHMP2B HGNC:24537 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.792 |
| CACNA2D2 HGNC:1400 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.791 |
| HNRNPU HGNC:5048 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.791 |
| FIG4 HGNC:16873 | Amyotrophic lateral sclerosis | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.791 |
| LDB3 HGNC:15710 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.791 |
| TNNC1 HGNC:11943 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.790 |
| ATP1A3 HGNC:801 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.790 |
| INSR HGNC:6091 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.789 |
| SLC1A2 HGNC:10940 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.789 |
| MAP3K1 HGNC:6848 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.788 |
| ALS2 HGNC:443 | Amyotrophic lateral sclerosis | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.788 |
| PFN1 HGNC:8881 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.788 |
| OTUD6B HGNC:24281 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.788 |
| ASAH1 HGNC:735 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.787 |
| EFHC1 HGNC:16406 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.787 |
| VPS35 HGNC:13487 | Parkinson disease | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.786 |
| UGDH HGNC:12525 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.786 |
| HACE1 HGNC:21033 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.785 |
| PTEN HGNC:9588 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.785 |
| SYNE1 HGNC:17089 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.785 |
| HNF1B HGNC:11630 | Type 2 diabetes mellitus | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.785 |
| SDHA HGNC:10680 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.784 |
| HCN1 HGNC:4845 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.784 |
| TTN HGNC:12403 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.783 |
| ABCC9 HGNC:60 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.783 |
| MAPK1 HGNC:6871 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.782 |
| RAD51D HGNC:9823 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.782 |
| NPRL2 HGNC:24969 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.782 |
| TCAP HGNC:11610 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.781 |
| SLC25A12 HGNC:10982 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.781 |
| BRIP1 HGNC:20473 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.780 |
| IL10 HGNC:5962 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.780 |
| HNF1A HGNC:11621 | Type 2 diabetes mellitus | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.780 |
| PACS2 HGNC:23794 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.779 |
| KCNB1 HGNC:6231 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.779 |
| CSRP3 HGNC:2472 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.778 |
| ADAM17 HGNC:195 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.778 |
| SYN1 HGNC:11494 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.777 |
| BRAT1 HGNC:21701 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.777 |
| HNF4A HGNC:5024 | Type 2 diabetes mellitus | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.776 |
| MRAS HGNC:7227 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.776 |
| SPG11 HGNC:11226 | Amyotrophic lateral sclerosis | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.775 |
| NEXN HGNC:29557 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.775 |
| APOE HGNC:613 | Alzheimer disease | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.775 |
| ANXA11 HGNC:535 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.774 |
| MT-ND4 HGNC:7459 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.774 |
| DHX37 HGNC:17210 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.774 |
| ALG13 HGNC:30881 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.773 |
| MAP3K1 HGNC:6848 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.771 |
| GOSR2 HGNC:4431 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.770 |
| ATP1A2 HGNC:800 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.770 |
| WFS1 HGNC:12762 | Type 2 diabetes mellitus | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.770 |
| CACNA2D1 HGNC:1399 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.769 |
| AARS1 HGNC:20 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.768 |
| RAF1 HGNC:9829 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.768 |
| DOCK7 HGNC:19190 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.768 |
| AP3B2 HGNC:567 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.768 |
| GABBR2 HGNC:4507 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.768 |
| MT-ND1 HGNC:7455 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.767 |
| GLP1R HGNC:4324 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.767 |
| TCAP HGNC:11610 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.767 |
| MYH6 HGNC:7576 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.765 |
| CHRNB2 HGNC:1962 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.765 |
| MT-CYB HGNC:7427 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.764 |
| PIGQ HGNC:14135 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.764 |
| FBXO28 HGNC:29046 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.764 |
| MT-ND6 HGNC:7462 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.763 |
| STRADA HGNC:30172 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.761 |
| MT-CO1 HGNC:7419 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.760 |
| VAPB HGNC:12649 | Amyotrophic lateral sclerosis | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.760 |
| KCNH5 HGNC:6254 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.759 |
| ACTL6B HGNC:160 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.759 |
| SYNJ1 HGNC:11503 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.758 |
| DMPK HGNC:2933 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.758 |
| MT-ATP6 HGNC:7414 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.758 |
| GRIN1 HGNC:4584 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.758 |
| FGFR2 HGNC:3689 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.757 |
| MT-ND5 HGNC:7461 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.756 |
| VPS13C HGNC:23594 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.755 |
| IL12B HGNC:5970 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.755 |
| KRAS HGNC:6407 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.754 |
| CACNA1H HGNC:1395 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.753 |
| RHOBTB2 HGNC:18756 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.753 |
| PRDM16 HGNC:14000 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.752 |
| PRICKLE1 HGNC:17019 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.751 |
| NR0B1 HGNC:7960 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.751 |
| PLN HGNC:9080 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.751 |
| TMEM43 HGNC:28472 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.750 |
| TBX3 HGNC:11602 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.750 |
| PLA2G6 HGNC:9039 | Parkinson disease | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.749 |
| DHH HGNC:2865 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.749 |
| FGF13 HGNC:3670 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.749 |
| RORB HGNC:10259 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.748 |
| PSEN1 HGNC:9508 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.748 |
| KCNQ3 HGNC:6297 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.748 |
| GBA1 HGNC:4177 | Parkinson disease | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.748 |
| MATR3 HGNC:6912 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.747 |
| CHRNA4 HGNC:1958 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.747 |
| NSD1 HGNC:14234 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.746 |
| PLN HGNC:9080 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.746 |
| CLN8 HGNC:2079 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.745 |
| DRD2 HGNC:3023 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.745 |
| FRRS1L HGNC:1362 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.744 |
| SLC2A2 HGNC:11006 | Type 2 diabetes mellitus | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.742 |
| CRYAB HGNC:2389 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.742 |
| GATA3 HGNC:4172 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.739 |
| ADAM22 HGNC:201 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.738 |
| DSG2 HGNC:3049 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.738 |
| ITGA4 HGNC:6140 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.738 |
| BARD1 HGNC:952 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.736 |
| SIGMAR1 HGNC:8157 | Amyotrophic lateral sclerosis | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.735 |
| CELF2 HGNC:2550 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.733 |
| SLC13A5 HGNC:23089 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.733 |
| CUX2 HGNC:19347 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.732 |
| SERPINI1 HGNC:8943 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.731 |
| NACC1 HGNC:20967 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.730 |
| SV2A HGNC:20566 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.729 |
| SPRED2 HGNC:17722 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.729 |
| ERBB4 HGNC:3432 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.729 |
| GABRA3 HGNC:4077 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.729 |
| CNPY3 HGNC:11968 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.728 |
| SIK1 HGNC:11142 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.727 |
| SLC32A1 HGNC:11018 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.725 |
| YWHAG HGNC:12852 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.725 |
| MT-ND4L HGNC:7460 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.725 |
| PLPBP HGNC:9457 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.724 |
| FLNC HGNC:3756 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.723 |
| SMC1A HGNC:11111 | Epilepsy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.722 |
| FOXA1 HGNC:5021 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.719 |
| LMOD2 HGNC:6648 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.719 |
| AKT2 HGNC:392 | Type 2 diabetes mellitus | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.718 |
| VCL HGNC:12665 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.717 |
| KIF5A HGNC:6323 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.717 |
| MAP2K4 HGNC:6844 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.716 |
| CAV3 HGNC:1529 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.715 |
| EYA4 HGNC:3522 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.715 |
| DSP HGNC:3052 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.714 |
| MT-ND2 HGNC:7456 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.713 |
| MAPT HGNC:6893 | Parkinson disease | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.713 |
| IL23R HGNC:19100 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.713 |
| SLC25A3 HGNC:10989 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.712 |
| HTT HGNC:4851 | Huntington disease | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.712 |
| KMT2C HGNC:13726 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.711 |
| MT-CO3 HGNC:7422 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.708 |
| GPD2 HGNC:4456 | Type 2 diabetes mellitus | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.707 |
| ATXN2 HGNC:10555 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.705 |
| SHANK3 HGNC:14294 | Schizophrenia | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.702 |
| NCOR1 HGNC:7672 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.702 |
| TNNT2 HGNC:11949 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.701 |
| GRIN1 HGNC:4584 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.700 |
| PPCS HGNC:25686 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.700 |
| SLC30A8 HGNC:20303 | Type 2 diabetes mellitus | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.697 |
| MYH7B HGNC:15906 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.697 |
| POLD1 HGNC:9175 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.695 |
| GRIN1 HGNC:4584 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.693 |
| NF1 HGNC:7765 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.693 |
| INAVA HGNC:25599 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.689 |
| SORL1 HGNC:11185 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.689 |
| PPM1D HGNC:9277 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.687 |
| CBFB HGNC:1539 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.687 |
| ERBB4 HGNC:3432 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.686 |
| ARID1A HGNC:11110 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.684 |
| RAD51B HGNC:9822 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.684 |
| CDK6 HGNC:1777 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.683 |
| FLAD1 HGNC:24671 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.682 |
| ADAM10 HGNC:188 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.682 |
| JAK2 HGNC:6192 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.681 |
| FBXO11 HGNC:13590 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.681 |
| CDK5 HGNC:1774 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.680 |
| RPL3L HGNC:10351 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.680 |
| CDK4 HGNC:1773 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.678 |
| POLE HGNC:9177 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.678 |
| TCF7L2 HGNC:11641 | Type 2 diabetes mellitus | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.677 |
| HNRNPA1 HGNC:5031 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.677 |
| C9orf72 HGNC:28337 | Amyotrophic lateral sclerosis | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.677 |
| TERT HGNC:11730 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.676 |
| PAX4 HGNC:8618 | Type 2 diabetes mellitus | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.676 |
| TBX20 HGNC:11598 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.676 |
| NDUFS4 HGNC:7711 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.675 |
| GIPR HGNC:4271 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.674 |
| RTN4R HGNC:18601 | Schizophrenia | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.674 |
| MYZAP HGNC:43444 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.673 |
| NEUROD1 HGNC:7762 | Type 2 diabetes mellitus | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.671 |
| C11orf65 HGNC:28519 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.670 |
| DRD3 HGNC:3024 | Schizophrenia | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.670 |
| GRIN3B HGNC:16768 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.669 |
| MSH2 HGNC:7325 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.669 |
| TIA1 HGNC:11802 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.667 |
| MSH6 HGNC:7329 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.667 |
| MLH1 HGNC:7127 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.665 |
| CHRM1 HGNC:1950 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.665 |
| EBF1 HGNC:3126 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.664 |
| FOXP1 HGNC:3823 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.664 |
| TTR HGNC:12405 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.662 |
| JPH2 HGNC:14202 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.659 |
| NOTCH2 HGNC:7882 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.659 |
| CUX1 HGNC:2557 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.657 |
| RAD50 HGNC:9816 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.656 |
| SYNE2 HGNC:17084 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.656 |
| IGF2 HGNC:5466 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.656 |
| MT-ND1 HGNC:7455 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.656 |
| TYK2 HGNC:12440 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.655 |
| PSAP HGNC:9498 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.654 |
| ENPP1 HGNC:3356 | Type 2 diabetes mellitus | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.654 |
| NBN HGNC:7652 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.653 |
| IL21 HGNC:6005 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.653 |
| SETBP1 HGNC:15573 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.652 |
| EGFR HGNC:3236 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.652 |
| MTHFR HGNC:7436 | Schizophrenia | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.652 |
| EGFR HGNC:3236 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.651 |
| CDC73 HGNC:16783 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.650 |
| RB1 HGNC:9884 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.649 |
| KSR2 HGNC:18610 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.645 |
| TNF HGNC:11892 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.645 |
| IL23A HGNC:15488 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.644 |
| FHIT HGNC:3701 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.644 |
| MLLT10 HGNC:16063 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.644 |
| PMS2 HGNC:9122 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.644 |
| DPP4 HGNC:3009 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.643 |
| SF3B1 HGNC:10768 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.643 |
| NDUFS3 HGNC:7710 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.643 |
| FANCD2 HGNC:3585 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.642 |
| CAP2 HGNC:20039 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.642 |
| DRD2 HGNC:3023 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.641 |
| CBX2 HGNC:1552 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.641 |
| CCND1 HGNC:1582 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.641 |
| TCF7L2 HGNC:11641 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.640 |
| ARRB1 HGNC:711 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.639 |
| H3C2 HGNC:4776 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.639 |
| KCNQ1 HGNC:6294 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.636 |
| SLC5A2 HGNC:11037 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.635 |
| HMGCR HGNC:5006 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.634 |
| BACH2 HGNC:14078 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.634 |
| ACE HGNC:2707 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.634 |
| BAG5 HGNC:941 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.634 |
| AR HGNC:644 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.634 |
| DROSHA HGNC:17904 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.633 |
| PTGS2 HGNC:9605 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.633 |
| HTR2A HGNC:5293 | Schizophrenia | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.633 |
| MUTYH HGNC:7527 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.633 |
| PPARG HGNC:9236 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.632 |
| TET2 HGNC:25941 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.631 |
| CYP19A1 HGNC:2594 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.631 |
| MAOB HGNC:6834 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.630 |
| CDKAL1 HGNC:21050 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.630 |
| DRD3 HGNC:3024 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.630 |
| COMT HGNC:2228 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.629 |
| NDUFB8 HGNC:7703 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.629 |
| ACHE HGNC:108 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.629 |
| TPM1 HGNC:12010 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.629 |
| IRF5 HGNC:6120 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.628 |
| GRIN2B HGNC:4586 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.627 |
| BCHE HGNC:983 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.627 |
| RAP1A HGNC:9855 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.627 |
| DRD1 HGNC:3020 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.627 |
| ITGB7 HGNC:6162 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.627 |
| NR3C1 HGNC:7978 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.627 |
| TUBB2B HGNC:30829 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.625 |
| HTR1A HGNC:5286 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.625 |
| RFX6 HGNC:21478 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.625 |
| GRIN2A HGNC:4585 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.625 |
| GRIN2B HGNC:4586 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.624 |
| DDC HGNC:2719 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.622 |
| MT-TI HGNC:7488 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.622 |
| PTGS1 HGNC:9604 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.621 |
| MYOZ2 HGNC:1330 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.621 |
| ACHE HGNC:108 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.620 |
| ATG16L1 HGNC:21498 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.620 |
| CDKN1B HGNC:1785 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.620 |
| SPTLC1 HGNC:11277 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.620 |
| DRD4 HGNC:3025 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.619 |
| ATM HGNC:795 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.619 |
| NDUFA13 HGNC:17194 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.619 |
| PPARA HGNC:9232 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.618 |
| NDUFA5 HGNC:7688 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.617 |
| NDUFB6 HGNC:7701 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.617 |
| NDUFV2 HGNC:7717 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.617 |
| MT-ND6 HGNC:7462 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.616 |
| MRTFA HGNC:14334 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.616 |
| GRIN2A HGNC:4585 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.615 |
| HTR1B HGNC:5287 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.615 |
| NDUFB2 HGNC:7697 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.615 |
| ALOX5 HGNC:435 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.614 |
| GRIN2A HGNC:4585 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.614 |
| NDUFC2 HGNC:7706 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.614 |
| GRIN2D HGNC:4588 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.614 |
| KLHL24 HGNC:25947 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.613 |
| HTR2C HGNC:5295 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.613 |
| DRD4 HGNC:3025 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.612 |
| NDUFAB1 HGNC:7694 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.612 |
| PIK3CB HGNC:8976 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.612 |
| BCHE HGNC:983 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.612 |
| CEP85L HGNC:21638 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.611 |
| CD274 HGNC:17635 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.611 |
| MT-ND2 HGNC:7456 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.611 |
| NDUFAF3 HGNC:29918 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.611 |
| NTRK3 HGNC:8033 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.611 |
| MT-ND4 HGNC:7459 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.610 |
| SUZ12 HGNC:17101 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.610 |
| GRIN3A HGNC:16767 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.610 |
| MT-ND4L HGNC:7460 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.610 |
| NDUFA10 HGNC:7684 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.609 |
| MT-ND5 HGNC:7461 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.609 |
| NDUFA1 HGNC:7683 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.609 |
| APH1B HGNC:24080 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.609 |
| NDUFA2 HGNC:7685 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.609 |
| NDUFS1 HGNC:7707 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.609 |
| MT-ND3 HGNC:7458 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.609 |
| GRIN2C HGNC:4587 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.608 |
| NDUFA12 HGNC:23987 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.608 |
| NDUFB7 HGNC:7702 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.608 |
| NDUFV1 HGNC:7716 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.608 |
| COXFA4 HGNC:7687 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.608 |
| NDUFS8 HGNC:7715 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.608 |
| NDUFA11 HGNC:20371 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.608 |
| NDUFA6 HGNC:7690 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.608 |
| NDUFAF1 HGNC:18828 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.608 |
| NDUFB10 HGNC:7696 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.608 |
| NDUFB4 HGNC:7699 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.608 |
| NDUFS5 HGNC:7712 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.608 |
| NDUFAF2 HGNC:28086 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.608 |
| TUBB3 HGNC:20772 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.608 |
| NDUFS2 HGNC:7708 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.608 |
| NDUFB3 HGNC:7698 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.608 |
| CDK5R1 HGNC:1775 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.607 |
| NDUFA8 HGNC:7692 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.607 |
| NDUFB5 HGNC:7700 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.607 |
| NDUFB9 HGNC:7704 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.607 |
| NDUFS7 HGNC:7714 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.607 |
| COXFA4L2 HGNC:29836 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.607 |
| NDUFA3 HGNC:7686 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.607 |
| NDUFA7 HGNC:7691 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.607 |
| NDUFA9 HGNC:7693 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.607 |
| NDUFAF4 HGNC:21034 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.607 |
| NDUFB1 HGNC:7695 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.607 |
| NDUFB11 HGNC:20372 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.607 |
| NDUFC1 HGNC:7705 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.607 |
| NDUFS6 HGNC:7713 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.607 |
| NDUFV2 HGNC:7717 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.607 |
| NDUFV3 HGNC:7719 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.607 |
| IL12A HGNC:5969 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.607 |
| JAK3 HGNC:6193 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.606 |
| HTR4 HGNC:5299 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.606 |
| ADORA2A HGNC:263 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.606 |
| DNAJC13 HGNC:30343 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.606 |
| GRIN2C HGNC:4587 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.606 |
| TUBB2A HGNC:12412 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.606 |
| GRIN2D HGNC:4588 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.605 |
| TUBA4A HGNC:12407 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.605 |
| BLM HGNC:1058 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.605 |
| HFE HGNC:4886 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.605 |
| TUBA1B HGNC:18809 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.605 |
| MGAM HGNC:7043 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.605 |
| NDUFA8 HGNC:7692 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.605 |
| NDUFS5 HGNC:7712 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.604 |
| TUBA1C HGNC:20768 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.604 |
| EIF4G1 HGNC:3296 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.603 |
| HTR6 HGNC:5301 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.603 |
| TUBB HGNC:20778 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.603 |
| GRIN3A HGNC:16767 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.602 |
| NDUFS1 HGNC:7707 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.602 |
| TUBB6 HGNC:20776 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.602 |
| GRIN3B HGNC:16768 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.602 |
| TUBA1A HGNC:20766 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.602 |
| KLF4 HGNC:6348 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.602 |
| TUBB4B HGNC:20771 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.601 |
| TUBA3E HGNC:20765 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.601 |
| TUBA3C HGNC:12408 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.600 |
| TUBB1 HGNC:16257 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.600 |
| TUBB4A HGNC:20774 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.600 |
| TUBB8 HGNC:20773 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.600 |
| SCN8A HGNC:10596 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.600 |
| AMY2A HGNC:477 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.600 |
| ITGB3 HGNC:6156 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.599 |
| CDC25B HGNC:1726 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.599 |
| ZFHX3 HGNC:777 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.598 |
| MDM2 HGNC:6973 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.598 |
| GRM3 HGNC:4595 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.598 |
| ACTB HGNC:132 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.598 |
| SCN4A HGNC:10591 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.598 |
| TRIM63 HGNC:16007 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.597 |
| TYMS HGNC:12441 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.597 |
| SCN1A HGNC:10585 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.597 |
| ARID1B HGNC:18040 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.595 |
| HTR5A HGNC:5300 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.595 |
| MYLK2 HGNC:16243 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.594 |
| HTR3A HGNC:5297 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.594 |
| MN1 HGNC:7180 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.594 |
| CDKN2A HGNC:1787 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.594 |
| HTR7 HGNC:5302 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.593 |
| HTR1F HGNC:5292 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.593 |
| CR1 HGNC:2334 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.593 |
| APOE HGNC:613 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.592 |
| S1PR1 HGNC:3165 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.592 |
| ITPKB HGNC:6179 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.592 |
| HTR3B HGNC:5298 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.592 |
| PPAT HGNC:9238 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.592 |
| SLC18A2 HGNC:10935 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.592 |
| ADRA2B HGNC:282 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.591 |
| GPR35 HGNC:4492 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.590 |
| BAG3 HGNC:939 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.590 |
| HTR3C HGNC:24003 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.589 |
| HTR3D HGNC:24004 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.589 |
| HTR3E HGNC:24005 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.589 |
| HTR2B HGNC:5294 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.589 |
| CHCHD2 HGNC:21645 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.589 |
| LRP1B HGNC:6693 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.589 |
| IRGM HGNC:29597 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.588 |
| IQGAP1 HGNC:6110 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.588 |
| HTR1D HGNC:5289 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.588 |
| KSR1 HGNC:6465 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.588 |
| FN1 HGNC:3778 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.588 |
| NDUFS2 HGNC:7708 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.587 |
| MT-ATP8 HGNC:7415 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.587 |
| YWHAB HGNC:12849 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.587 |
| HSPA1L HGNC:5234 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.586 |
| HTR1E HGNC:5291 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.586 |
| TOP1 HGNC:11986 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.585 |
| SCN5A HGNC:10593 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.585 |
| HMGCR HGNC:5006 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.585 |
| SETD1A HGNC:29010 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.585 |
| MYH9 HGNC:7579 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.584 |
| ARAF HGNC:646 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.584 |
| PAX5 HGNC:8619 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.584 |
| VWF HGNC:12726 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.584 |
| SACS HGNC:10519 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.584 |
| FAT4 HGNC:23109 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.583 |
| SCN2A HGNC:10588 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.583 |
| SCN7A HGNC:10594 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.583 |
| MDM4 HGNC:6974 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.583 |
| SCN10A HGNC:10582 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.583 |
| SCN11A HGNC:10583 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.583 |
| SCN3A HGNC:10590 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.583 |
| SCN9A HGNC:10597 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.583 |
| MITF HGNC:7105 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.583 |
| HADHB HGNC:4803 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.582 |
| MT-CO2 HGNC:7421 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.582 |
| PRKAG2 HGNC:9386 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.582 |
| GAA HGNC:4065 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.582 |
| CD33 HGNC:1659 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.582 |
| FGA HGNC:3661 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.582 |
| HTR2C HGNC:5295 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.582 |
| NEK1 HGNC:7744 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.581 |
| GRN HGNC:4601 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.581 |
| EPHA1 HGNC:3385 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.581 |
| TLN1 HGNC:11845 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.580 |
| MAPK3 HGNC:6877 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.580 |
| GATAD1 HGNC:29941 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.580 |
| POLD2 HGNC:9176 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.580 |
| ADRB1 HGNC:285 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.580 |
| KDM6A HGNC:12637 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.579 |
| NDUFA9 HGNC:7693 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.579 |
| PPP1R13L HGNC:18838 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.579 |
| ITGA2B HGNC:6138 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.579 |
| MECOM HGNC:3498 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.579 |
| FGFR4 HGNC:3691 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.579 |
| UBR5 HGNC:16806 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.578 |
| MYL7 HGNC:21719 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.578 |
| BRCA2 HGNC:1101 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.578 |
| ACTG1 HGNC:144 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.578 |
| TGFBR2 HGNC:11773 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.578 |
| SRC HGNC:11283 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.577 |
| RRM2 HGNC:10452 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.577 |
| CNKSR1 HGNC:19700 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.577 |
| ATP2B3 HGNC:816 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.577 |
| KAT6B HGNC:17582 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.576 |
| CSK HGNC:2444 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.576 |
| FGB HGNC:3662 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.576 |
| APBB1IP HGNC:17379 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.576 |
| ARRB2 HGNC:712 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.576 |
| CNKSR2 HGNC:19701 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.576 |
| FGG HGNC:3694 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.576 |
| MARK3 HGNC:6897 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.576 |
| RAP1B HGNC:9857 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.576 |
| PAM HGNC:8596 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.575 |
| MYL4 HGNC:7585 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.575 |
| TNFSF15 HGNC:11931 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.574 |
| PLAG1 HGNC:9045 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.574 |
| NDUFAB1 HGNC:7694 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.574 |
| TBL1XR1 HGNC:29529 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.574 |
| FOXO3 HGNC:3821 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.574 |
| PRC1 HGNC:9341 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.574 |
| ERBB3 HGNC:3431 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.573 |
| NDUFB7 HGNC:7702 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.573 |
| MASP2 HGNC:6902 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.573 |
| S1PR5 HGNC:14299 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.572 |
| TREM2 HGNC:17761 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.572 |
| NRG1 HGNC:7997 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.572 |
| UBE2E2 HGNC:12478 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.571 |
| MTNR1B HGNC:7464 | Type 2 diabetes mellitus | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.571 |
| ABL2 HGNC:77 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.571 |
| FCGR2A HGNC:3616 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.570 |
| RBM12 HGNC:9898 | Schizophrenia | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.570 |
| TMEM175 HGNC:28709 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.569 |
| SI HGNC:10856 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.569 |
| KCNQ1 HGNC:6294 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.569 |
| NDUFB11 HGNC:20372 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.569 |
| TP63 HGNC:15979 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.569 |
| STAT3 HGNC:11364 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.569 |
| MGAM2 HGNC:28101 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.568 |
| CFAP410 HGNC:1260 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.568 |
| ACTN2 HGNC:164 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.568 |
| JAZF1 HGNC:28917 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.568 |
| RRM1 HGNC:10451 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.567 |
| ARHGAP35 HGNC:4591 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.567 |
| PRDM1 HGNC:9346 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.567 |
| NTRK2 HGNC:8032 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.567 |
| PREX2 HGNC:22950 | Breast carcinoma | single source observed | automatic checks only | Open Targets Platform | 1 | 0.567 |
| HTR2A HGNC:5293 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.566 |
| GLA HGNC:4296 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.566 |
| LPL HGNC:6677 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.566 |
| ABCA7 HGNC:37 | Alzheimer disease | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.565 |
| KSR2 HGNC:18610 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.565 |
| GRP HGNC:4605 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.565 |
| ITGB1 HGNC:6153 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.565 |
| CTRB1 HGNC:2521 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.564 |
| BST1 HGNC:1118 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.563 |
| NKX2-3 HGNC:7836 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.563 |
| FLII HGNC:3750 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.563 |
| LACC1 HGNC:26789 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.563 |
| CEP85L HGNC:21638 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.562 |
| PDX1 HGNC:6107 | Type 2 diabetes mellitus | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.561 |
| RPS27A HGNC:10417 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.561 |
| NDUFAB1 HGNC:7694 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.561 |
| CD40 HGNC:11919 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.560 |
| AGTR1 HGNC:336 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.559 |
| MST1 HGNC:7380 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.559 |
| HMGA2 HGNC:5009 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.559 |
| CTRB2 HGNC:2522 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.559 |
| KL HGNC:6344 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.559 |
| FGFR4 HGNC:3691 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.558 |
| IGF2BP2 HGNC:28867 | Type 2 diabetes mellitus | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.558 |
| LIPC HGNC:6619 | Type 2 diabetes mellitus | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.557 |
| DM1-AS HGNC:53125 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.557 |
| S1PR4 HGNC:3170 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.556 |
| CLU HGNC:2095 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.556 |
| BIN1 HGNC:1052 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.555 |
| PTPA HGNC:9308 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.554 |
| SYNJ1 HGNC:11503 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.554 |
| SLC6A3 HGNC:11049 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.554 |
| ANKH HGNC:15492 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.554 |
| GSK3B HGNC:4617 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.553 |
| RNF186 HGNC:25978 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.553 |
| CDKN2B HGNC:1788 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.553 |
| RASGRP1 HGNC:9878 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.553 |
| GRB14 HGNC:4565 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.552 |
| PLCG2 HGNC:9066 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.551 |
| CACNA1I HGNC:1396 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.551 |
| PTPN22 HGNC:9652 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.551 |
| NR3C2 HGNC:7979 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.551 |
| FES HGNC:3657 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.550 |
| CDKN1A HGNC:1784 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.550 |
| PROX1 HGNC:9459 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.550 |
| OTUD3 HGNC:29038 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.549 |
| NCK2 HGNC:7665 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.549 |
| LIMS2 HGNC:16084 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.548 |
| PSAP HGNC:9498 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.548 |
| PRKCB HGNC:9395 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.548 |
| PODXL HGNC:9171 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.547 |
| IFNGR2 HGNC:5440 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.547 |
| SMPD1 HGNC:11120 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.547 |
| NRAP HGNC:7988 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.546 |
| MT-TI HGNC:7488 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.546 |
| SPRED2 HGNC:17722 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.546 |
| NDUFB9 HGNC:7704 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.546 |
| LAMP2 HGNC:6501 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.546 |
| HLX HGNC:4978 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.545 |
| TLE1 HGNC:11837 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.545 |
| GALT HGNC:4135 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.544 |
| PNPLA3 HGNC:18590 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.544 |
| NDUFC2 HGNC:7706 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.544 |
| LAMA4 HGNC:6484 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.544 |
| CCL20 HGNC:10619 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.544 |
| NFKBIA HGNC:7797 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.543 |
| SLC39A8 HGNC:20862 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.542 |
| CSF2RB HGNC:2436 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.542 |
| ETS1 HGNC:3488 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.542 |
| PLK1 HGNC:9077 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.542 |
| CDK4 HGNC:1773 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.542 |
| MAP3K8 HGNC:6860 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.542 |
| SMPD1 HGNC:11120 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.542 |
| GSK3B HGNC:4617 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.542 |
| NDUFS8 HGNC:7715 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.541 |
| NDUFA6 HGNC:7690 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.541 |
| CDKN1A HGNC:1784 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.541 |
| DGKB HGNC:2850 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.540 |
| SLC5A1 HGNC:11036 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.540 |
| ADCY7 HGNC:238 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.540 |
| SCN8A HGNC:10596 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.540 |
| NDUFA5 HGNC:7688 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.540 |
| SLC22A3 HGNC:10967 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.538 |
| PTPN2 HGNC:9650 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.538 |
| MS4A6A HGNC:13375 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.538 |
| RGS6 HGNC:10002 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.538 |
| JAK1 HGNC:6190 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.538 |
| TSPAN8 HGNC:11855 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.538 |
| SMAD3 HGNC:6769 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.537 |
| FGFR3 HGNC:3690 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.537 |
| CHRM3 HGNC:1952 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.537 |
| IRS1 HGNC:6125 | Type 2 diabetes mellitus | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.536 |
| CD6 HGNC:1691 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.536 |
| GRN HGNC:4601 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.535 |
| SCN1A HGNC:10585 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.535 |
| KLF14 HGNC:23025 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.535 |
| MT-ND1 HGNC:7455 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.535 |
| TRIM66 HGNC:29005 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.535 |
| PRL HGNC:9445 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.535 |
| ATXN7 HGNC:10560 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.535 |
| SCARB1 HGNC:1664 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.535 |
| AXL HGNC:905 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.534 |
| CCND2 HGNC:1583 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.534 |
| TFAP2B HGNC:11743 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.534 |
| GPM6A HGNC:4460 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.534 |
| GLIS3 HGNC:28510 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.534 |
| NEUROG3 HGNC:13806 | Type 2 diabetes mellitus | single source observed | automatic checks only | Open Targets Platform | 1 | 0.534 |
| NDUFS5 HGNC:7712 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.534 |
| NRXN1 HGNC:8008 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.534 |
| DLD HGNC:2898 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.534 |
| MKRN2 HGNC:7113 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.533 |
| PARK7 HGNC:16369 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.533 |
| GPR65 HGNC:4517 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.533 |
| IGSF9B HGNC:32326 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.532 |
| PITX2 HGNC:9005 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.532 |
| DNASE1L1 HGNC:2957 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.531 |
| DRD5 HGNC:3026 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.531 |
| CDKN1A HGNC:1784 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.530 |
| SLC26A3 HGNC:3018 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.530 |
| CASZ1 HGNC:26002 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.530 |
| HTR1A HGNC:5286 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.529 |
| GPNMB HGNC:4462 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.529 |
| AURKB HGNC:11390 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.529 |
| NDUFA8 HGNC:7692 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.528 |
| TCF4 HGNC:11634 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.528 |
| NDUFV2 HGNC:7717 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.528 |
| AXL HGNC:905 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.528 |
| PLK1 HGNC:9077 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.527 |
| CDK4 HGNC:1773 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.527 |
| NDUFC1 HGNC:7705 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.527 |
| LSM6 HGNC:17017 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.527 |
| CHRM2 HGNC:1951 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.527 |
| MTMR3 HGNC:7451 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.526 |
| AURKB HGNC:11390 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.526 |
| LSM6 HGNC:17017 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.526 |
| IL19 HGNC:5990 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.525 |
| SLC6A2 HGNC:11048 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.525 |
| CDKN2A HGNC:1787 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.525 |
| CDKN1C HGNC:1786 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.525 |
| CDK1 HGNC:1722 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.525 |
| RIT2 HGNC:10017 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.525 |
| RIOK2 HGNC:18999 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.524 |
| RIOK2 HGNC:18999 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.524 |
| GET3 HGNC:752 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.524 |
| LDB3 HGNC:15710 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.524 |
| DRD2 HGNC:3023 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.524 |
| CDKN1C HGNC:1786 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.524 |
| ESAM HGNC:17474 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.524 |
| NR4A2 HGNC:7981 | Parkinson disease | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.524 |
| BRCA1 HGNC:1100 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.523 |
| NDUFS1 HGNC:7707 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.523 |
| PSEN2 HGNC:9509 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.523 |
| DDX39B HGNC:13917 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.522 |
| RNASE4 HGNC:10047 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.522 |
| HMGCL HGNC:5005 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.522 |
| NDUFV1 HGNC:7716 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.522 |
| TMCO4 HGNC:27393 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.522 |
| ATP6V1B2 HGNC:854 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.521 |
| TAGAP HGNC:15669 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.521 |
| IL2RA HGNC:6008 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.520 |
| HMGCR HGNC:5006 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.520 |
| SCN3A HGNC:10590 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.520 |
| TNRC18 HGNC:11962 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.520 |
| SLC6A2 HGNC:11048 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.520 |
| SCN2A HGNC:10588 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.520 |
| SCN5A HGNC:10593 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.520 |
| PICALM HGNC:15514 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.519 |
| RIPK1 HGNC:10019 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.519 |
| CD2AP HGNC:14258 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.519 |
| ATP6V1B2 HGNC:854 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.519 |
| SCN9A HGNC:10597 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.519 |
| UQCRC1 HGNC:12585 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.518 |
| ATP6V1A HGNC:851 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.518 |
| PRKCA HGNC:9393 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.518 |
| SCN7A HGNC:10594 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.518 |
| SCN10A HGNC:10582 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.518 |
| SCN11A HGNC:10583 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.518 |
| SCN4A HGNC:10591 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.518 |
| ZNF804A HGNC:21711 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.518 |
| ADRA2C HGNC:283 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.516 |
| CCND1 HGNC:1582 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.516 |
| SH3GL2 HGNC:10831 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.516 |
| AURKA HGNC:11393 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.516 |
| CARD9 HGNC:16391 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.516 |
| TRIM22 HGNC:16379 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.515 |
| NDUFB4 HGNC:7699 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.515 |
| IRF1 HGNC:6116 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.515 |
| CDK1 HGNC:1722 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.515 |
| STK39 HGNC:17717 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.513 |
| HIP1R HGNC:18415 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.512 |
| ADRA2A HGNC:281 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.512 |
| MPO HGNC:7218 | Alzheimer disease | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.512 |
| DENND1B HGNC:28404 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.511 |
| NDUFS2 HGNC:7708 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.511 |
| NR5A2 HGNC:7984 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.511 |
| TGFBR2 HGNC:11773 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.511 |
| CASS4 HGNC:15878 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.510 |
| IAH1 HGNC:27696 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.510 |
| FOSL2 HGNC:3798 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.510 |
| UQCRC1 HGNC:12585 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.510 |
| TMTC1 HGNC:24099 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.510 |
| SLC18A2 HGNC:10935 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.509 |
| IL37 HGNC:15563 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.509 |
| PIKFYVE HGNC:23785 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.509 |
| PJA1 HGNC:16648 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.509 |
| PPP1R16B HGNC:15850 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.509 |
| NDFIP1 HGNC:17592 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.508 |
| CAMLG HGNC:1471 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.508 |
| SLC6A2 HGNC:11048 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.507 |
| NDUFA9 HGNC:7693 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.506 |
| CSMD1 HGNC:14026 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.506 |
| SYK HGNC:11491 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.506 |
| KAT8 HGNC:17933 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.506 |
| RUNX3 HGNC:10473 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.506 |
| UNC13A HGNC:23150 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.505 |
| CDC25B HGNC:1726 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.505 |
| TNFAIP3 HGNC:11896 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.505 |
| NR1H2 HGNC:7965 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.505 |
| SLC7A10 HGNC:11058 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.505 |
| PACRG HGNC:19152 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.504 |
| CSNK1A1 HGNC:2451 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.504 |
| TET2 HGNC:25941 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.504 |
| NR1H2 HGNC:7965 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.504 |
| ERF HGNC:3444 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.504 |
| ALPI HGNC:437 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.503 |
| AKAP11 HGNC:369 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.503 |
| AKAP11 HGNC:369 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.503 |
| DDX39B HGNC:13917 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.503 |
| MASTL HGNC:19042 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.503 |
| MASTL HGNC:19042 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.503 |
| MTMR3 HGNC:7451 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.503 |
| TARS2 HGNC:30740 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.503 |
| TARS2 HGNC:30740 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.503 |
| ATP6V1C1 HGNC:856 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.503 |
| CDKN2A HGNC:1787 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.503 |
| KCNH2 HGNC:6251 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.503 |
| MT-ND3 HGNC:7458 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.503 |
| BCL11B HGNC:13222 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.503 |
| TSPAN14 HGNC:23303 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.503 |
| PLCG2 HGNC:9066 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.502 |
| PIKFYVE HGNC:23785 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.502 |
| ATP6V1C1 HGNC:856 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.502 |
| FADS2 HGNC:3575 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.502 |
| CDK12 HGNC:24224 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.502 |
| ZSWIM6 HGNC:29316 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.502 |
| CTSB HGNC:2527 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.501 |
| CDK12 HGNC:24224 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.501 |
| SLC22A4 HGNC:10968 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.501 |
| LITAF HGNC:16841 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.501 |
| SPEG HGNC:16901 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.501 |
| PRPH HGNC:9461 | Amyotrophic lateral sclerosis | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.501 |
| CHRNA3 HGNC:1957 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.500 |
| ZBTB38 HGNC:26636 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.500 |
| APOE HGNC:613 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.500 |
| IFIH1 HGNC:18873 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.499 |
| IL12RB2 HGNC:5972 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.499 |
| PI4KB HGNC:8984 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.499 |
| PI4KB HGNC:8984 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.499 |
| LAMP2 HGNC:6501 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.499 |
| CACNA1C HGNC:1390 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.499 |
| ATP6V1A HGNC:851 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.499 |
| ADPRHL1 HGNC:21303 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.499 |
| CDKN2B HGNC:1788 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.499 |
| AURKA HGNC:11393 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.499 |
| CORIN HGNC:19012 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.498 |
| NDUFB7 HGNC:7702 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.498 |
| MTMR6 HGNC:7453 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.498 |
| MTMR6 HGNC:7453 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.498 |
| CSNK1A1 HGNC:2451 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.497 |
| DRD1 HGNC:3020 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.496 |
| MKRN2 HGNC:7113 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.496 |
| WSCD2 HGNC:29117 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.496 |
| NCF4 HGNC:7662 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.496 |
| RASGRP1 HGNC:9878 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.496 |
| H2BC4 HGNC:4757 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.495 |
| ADRA1A HGNC:277 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.495 |
| LRP12 HGNC:31708 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.495 |
| TP53 HGNC:11998 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.495 |
| THOC7 HGNC:29874 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.495 |
| CAMLG HGNC:1471 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.495 |
| GABRP HGNC:4089 | Parkinson disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.495 |
| HCN1 HGNC:4845 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.494 |
| CDKAL1 HGNC:21050 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.494 |
| OSMR HGNC:8507 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.494 |
| MTOR HGNC:3942 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.494 |
| KIF1A HGNC:888 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.493 |
| NXPE1 HGNC:28527 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.493 |
| IKZF1 HGNC:13176 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.493 |
| NEFH HGNC:7737 | Amyotrophic lateral sclerosis | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.493 |
| PUS10 HGNC:26505 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.493 |
| TNIP1 HGNC:16903 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.492 |
| ADRA1D HGNC:280 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.492 |
| CCL2 HGNC:10618 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.492 |
| ACTC1 HGNC:143 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.492 |
| GALC HGNC:4115 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.491 |
| SPRED2 HGNC:17722 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.491 |
| IL18R1 HGNC:5988 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.491 |
| HSPB7 HGNC:5249 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.490 |
| SP140 HGNC:17133 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.490 |
| ADRA1B HGNC:278 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.490 |
| FOS HGNC:3796 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.489 |
| MUC19 HGNC:14362 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.489 |
| TGFB1 HGNC:11766 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.489 |
| IL18RAP HGNC:5989 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.489 |
| NEU1 HGNC:7758 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.489 |
| CALCA HGNC:1437 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.488 |
| FUT9 HGNC:4020 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.488 |
| OGG1 HGNC:8125 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.488 |
| CACNA1C HGNC:1390 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.488 |
| PIK3CB HGNC:8976 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.487 |
| ADO HGNC:23506 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.487 |
| SNCA HGNC:11138 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.487 |
| RRAS HGNC:10447 | Hypertrophic cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.486 |
| BCL11A HGNC:13221 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.486 |
| MMP16 HGNC:7162 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.485 |
| CEP43 HGNC:17012 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.484 |
| JAZF1 HGNC:28917 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.484 |
| GIGYF2 HGNC:11960 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.483 |
| TLR4 HGNC:11850 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.483 |
| TGFBR2 HGNC:11773 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.483 |
| MYLK3 HGNC:29826 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.483 |
| BMS1 HGNC:23505 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.482 |
| CLK2 HGNC:2069 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.482 |
| CD28 HGNC:1653 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.482 |
| GABRP HGNC:4089 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.481 |
| ADCY3 HGNC:234 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.481 |
| SNAP91 HGNC:14986 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.481 |
| SCD HGNC:10571 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.481 |
| DRD3 HGNC:3024 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.480 |
| SDCCAG8 HGNC:10671 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.480 |
| ATP2A2 HGNC:812 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.480 |
| PDGFB HGNC:8800 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.479 |
| NOC4L HGNC:28461 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.479 |
| ZFP36L1 HGNC:1107 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.479 |
| XPO1 HGNC:12825 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.478 |
| BANK1 HGNC:18233 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.478 |
| NRGN HGNC:8000 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.478 |
| VRK2 HGNC:12719 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.478 |
| AP2S1 HGNC:565 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.477 |
| DRD4 HGNC:3025 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.477 |
| SLC24A4 HGNC:10978 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.477 |
| UBASH3A HGNC:12462 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.477 |
| INPP5D HGNC:6079 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.477 |
| CYLD HGNC:2584 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.477 |
| SHARPIN HGNC:25321 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.477 |
| DPYD HGNC:3012 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.476 |
| CHRM3 HGNC:1952 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.475 |
| RNF5 HGNC:10068 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.475 |
| TGFBR1 HGNC:11772 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.475 |
| RAB7A HGNC:9788 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.475 |
| KLF6 HGNC:2235 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.475 |
| CARD8 HGNC:17057 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.474 |
| BNIP3L HGNC:1085 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.474 |
| MOB3B HGNC:23825 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.474 |
| ZNF536 HGNC:29025 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.474 |
| PTPN1 HGNC:9642 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.473 |
| CUL3 HGNC:2553 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.473 |
| YWHAE HGNC:12851 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.473 |
| CLTC HGNC:2092 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.473 |
| PPT1 HGNC:9325 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.473 |
| RRP15 HGNC:24255 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.473 |
| IMMP2L HGNC:14598 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.473 |
| DAO HGNC:2671 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.472 |
| ADAP1 HGNC:16486 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.472 |
| XIAP HGNC:592 | Inflammatory bowel disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.472 |
| RASGEF1C HGNC:27400 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.470 |
| OPRK1 HGNC:8154 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.470 |
| NDUFS8 HGNC:7715 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.470 |
| FCF1 HGNC:20220 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.469 |
| NDUFB9 HGNC:7704 | Alzheimer disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.469 |
| SLC6A3 HGNC:11049 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.468 |
| ATXN7 HGNC:10560 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.468 |
| OPRM1 HGNC:8156 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.468 |
| AKT3 HGNC:393 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.468 |
| UBC HGNC:12468 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.467 |
| UBA52 HGNC:12458 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.467 |
| UBB HGNC:12463 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.467 |
| GGNBP2 HGNC:19357 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.466 |
| RNF185 HGNC:26783 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.466 |
| PDE4B HGNC:8781 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.465 |
| NCAM1 HGNC:7656 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.465 |
| MAD1L1 HGNC:6762 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.465 |
| GRAMD1B HGNC:29214 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.465 |
| DERL2 HGNC:17943 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.465 |
| AS3MT HGNC:17452 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.465 |
| VCP HGNC:12666 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.464 |
| SORCS3 HGNC:16699 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.464 |
| HAND2 HGNC:4808 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.464 |
| OPRD1 HGNC:8153 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.464 |
| OS9 HGNC:16994 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.464 |
| DERL1 HGNC:28454 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.463 |
| UBQLN4 HGNC:1237 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.463 |
| DERL3 HGNC:14236 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.462 |
| ERLEC1 HGNC:25222 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.462 |
| ERLIN1 HGNC:16947 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.462 |
| ERLIN2 HGNC:1356 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.462 |
| MT-TT HGNC:7499 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.462 |
| SEL1L HGNC:10717 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.462 |
| KCNG2 HGNC:6249 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.461 |
| EMX1 HGNC:3340 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.460 |
| CHRM4 HGNC:1953 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.460 |
| SATB2 HGNC:21637 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.460 |
| CALN1 HGNC:13248 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.459 |
| SLC26A9 HGNC:14469 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.458 |
| KCNB1 HGNC:6231 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.458 |
| VSIG2 HGNC:17149 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.458 |
| TSNARE1 HGNC:26437 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.457 |
| CARMIL1 HGNC:21581 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.457 |
| C10orf71 HGNC:26973 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.456 |
| SRPK2 HGNC:11306 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.456 |
| ZDHHC2 HGNC:18469 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.455 |
| DNAJC30 HGNC:16410 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.455 |
| SNX19 HGNC:21532 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.455 |
| MAN2A1 HGNC:6824 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.455 |
| VEZF1 HGNC:12949 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.454 |
| NEGR1 HGNC:17302 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.454 |
| FOXP1 HGNC:3823 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.451 |
| CNTN4 HGNC:2174 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.450 |
| SPATS2L HGNC:24574 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.449 |
| PRKD1 HGNC:9407 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.447 |
| ACE HGNC:2707 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.446 |
| ACTA1 HGNC:129 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.445 |
| GDNF HGNC:4232 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.445 |
| ANKRD1 HGNC:15819 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.444 |
| TGFB1 HGNC:11766 | Cystic fibrosis | multi source observed | automatic checks only | ClinVar, Open Targets Platform | 2 | 0.444 |
| MOBP HGNC:7189 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.444 |
| SCN1A HGNC:10585 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.443 |
| FXR1 HGNC:4023 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.442 |
| SYNE1 HGNC:17089 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.441 |
| KCNQ5 HGNC:6299 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.440 |
| ESR2 HGNC:3468 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.440 |
| VRK1 HGNC:12718 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.439 |
| GPX3 HGNC:4555 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.439 |
| ENOX1 HGNC:25474 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.439 |
| ITIH3 HGNC:6168 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.438 |
| GRIA1 HGNC:4571 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.438 |
| GALNT10 HGNC:19873 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.438 |
| NDUFS2 HGNC:7708 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.438 |
| CPNE1 HGNC:2314 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.437 |
| ZFPM2 HGNC:16700 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.436 |
| NMUR2 HGNC:16454 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.432 |
| RALGPS1 HGNC:16851 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.431 |
| PTBP2 HGNC:17662 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.429 |
| TXNRD2 HGNC:18155 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.428 |
| SPHKAP HGNC:30619 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.427 |
| CDKN1A HGNC:1784 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.426 |
| SLC6A3 HGNC:11049 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.426 |
| FOXO3 HGNC:3821 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.424 |
| TFAP2B HGNC:11743 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.423 |
| CHRM1 HGNC:1950 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.423 |
| SGCD HGNC:10807 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.422 |
| ATF7IP HGNC:20092 | Schizophrenia | single source observed | automatic checks only | Open Targets Platform | 1 | 0.422 |
| PLEKHG5 HGNC:29105 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.421 |
| SERPINA1 HGNC:8941 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.421 |
| FHL2 HGNC:3703 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.420 |
| TMPO HGNC:11875 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.419 |
| CCNF HGNC:1591 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.418 |
| HFE HGNC:4886 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.418 |
| GLE1 HGNC:4315 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.412 |
| CHCHD10 HGNC:15559 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.411 |
| SS18L1 HGNC:15592 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.405 |
| DNAJC7 HGNC:12392 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.405 |
| PON1 HGNC:9204 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.404 |
| TMEM106B HGNC:22407 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.403 |
| SLC11A1 HGNC:10907 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.400 |
| TAF1A HGNC:11532 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.399 |
| NKX2-5 HGNC:2488 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.396 |
| SLC6A14 HGNC:11047 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.394 |
| IFNGR2 HGNC:5440 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.394 |
| DRD2 HGNC:3023 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.394 |
| RPL17 HGNC:10307 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.392 |
| CLCA4 HGNC:2018 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.391 |
| CAMK2D HGNC:1462 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.391 |
| RPSA HGNC:6502 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.390 |
| IFNGR1 HGNC:5439 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.390 |
| RPL12 HGNC:10302 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.390 |
| RPL4 HGNC:10353 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.390 |
| RPS3A HGNC:10421 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.389 |
| RPS15A HGNC:10389 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.389 |
| SLC2A3 HGNC:11007 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.389 |
| RPL9 HGNC:10369 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.389 |
| RPLP0 HGNC:10371 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.389 |
| RPLP1 HGNC:10372 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.389 |
| RPL22 HGNC:10315 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL31 HGNC:10334 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL34 HGNC:10340 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL6 HGNC:10362 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS24 HGNC:10411 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| PPARGC1A HGNC:9237 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| FAU HGNC:3597 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL10 HGNC:10298 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL10A HGNC:10299 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL11 HGNC:10301 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL13 HGNC:10303 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL13A HGNC:10304 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL14 HGNC:10305 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL15 HGNC:10306 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL18 HGNC:10310 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL18A HGNC:10311 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL19 HGNC:10312 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL21 HGNC:10313 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL23 HGNC:10316 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL23A HGNC:10317 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL24 HGNC:10325 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL26 HGNC:10327 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL27 HGNC:10328 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL27A HGNC:10329 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL28 HGNC:10330 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL29 HGNC:10331 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL3 HGNC:10332 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL30 HGNC:10333 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL32 HGNC:10336 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL35 HGNC:10344 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL35A HGNC:10345 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL36 HGNC:13631 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL36A HGNC:10359 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL37 HGNC:10347 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL37A HGNC:10348 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL38 HGNC:10349 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL39 HGNC:10350 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL41 HGNC:10354 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL5 HGNC:10360 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL7 HGNC:10363 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL7A HGNC:10364 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPL8 HGNC:10368 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS10 HGNC:10383 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS11 HGNC:10384 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS12 HGNC:10385 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS13 HGNC:10386 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS14 HGNC:10387 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS15 HGNC:10388 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS16 HGNC:10396 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS17 HGNC:10397 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS18 HGNC:10401 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS19 HGNC:10402 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS2 HGNC:10404 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS20 HGNC:10405 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS21 HGNC:10409 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS23 HGNC:10410 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS25 HGNC:10413 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS26 HGNC:10414 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS27 HGNC:10416 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS28 HGNC:10418 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS29 HGNC:10419 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS3 HGNC:10420 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS4X HGNC:10424 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS4Y1 HGNC:10425 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS5 HGNC:10426 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS6 HGNC:10429 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS7 HGNC:10440 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS8 HGNC:10441 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| RPS9 HGNC:10442 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| HMOX1 HGNC:5013 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.388 |
| SPTLC2 HGNC:11278 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.387 |
| KCNN4 HGNC:6293 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.386 |
| CHRNA3 HGNC:1957 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.384 |
| ESR2 HGNC:3468 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.384 |
| MIF HGNC:7097 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.383 |
| DCTN4 HGNC:15518 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.381 |
| INSR HGNC:6091 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.380 |
| GSTM3 HGNC:4635 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.376 |
| SLC9A3 HGNC:11073 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.375 |
| EDNRA HGNC:3179 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.375 |
| LZTR1 HGNC:6742 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.375 |
| CEACAM3 HGNC:1815 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.374 |
| KCNJ11 HGNC:6257 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.374 |
| GCLC HGNC:4311 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.373 |
| ADRA2B HGNC:282 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.373 |
| RRM2B HGNC:17296 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.373 |
| TNNC2 HGNC:11944 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.372 |
| TNNI2 HGNC:11946 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.372 |
| TNNT3 HGNC:11950 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.372 |
| FGGY HGNC:25610 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.372 |
| PON3 HGNC:9206 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.372 |
| PON2 HGNC:9205 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.371 |
| PPA2 HGNC:28883 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.371 |
| STX1A HGNC:11433 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.371 |
| CEACAM6 HGNC:1818 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.370 |
| PCCB HGNC:8654 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.370 |
| ADRA2A HGNC:281 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.370 |
| ADRA2C HGNC:283 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.370 |
| PCCA HGNC:8653 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.370 |
| P2RY2 HGNC:8541 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.369 |
| NEBL HGNC:16932 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.367 |
| PRKCA HGNC:9393 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.362 |
| JUP HGNC:6207 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.359 |
| DRD2 HGNC:3023 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.355 |
| TAB2 HGNC:17075 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.355 |
| LINGO2 HGNC:21207 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.354 |
| PDE3A HGNC:8778 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.353 |
| ACE HGNC:2707 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.352 |
| FGFR3 HGNC:3690 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.352 |
| DSC2 HGNC:3036 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.348 |
| PDGFRA HGNC:8803 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.348 |
| KIT HGNC:6342 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.348 |
| LAMA2 HGNC:6482 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.346 |
| KLF5 HGNC:6349 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.346 |
| MYL2 HGNC:7583 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.346 |
| PDGFRB HGNC:8804 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.345 |
| GPR17 HGNC:4471 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.345 |
| CCSAP HGNC:29578 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.344 |
| DTNA HGNC:3057 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.344 |
| ERLIN1 HGNC:16947 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.344 |
| TUBA1A HGNC:20766 | Dilated cardiomyopathy | single source observed | automatic checks only | Open Targets Platform | 1 | 0.342 |
| AKAP12 HGNC:370 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.341 |
| CHD7 HGNC:20626 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.341 |
| CLN6 HGNC:2077 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.340 |
| FBN2 HGNC:3604 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.339 |
| TNNT2 HGNC:11949 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.337 |
| NOG HGNC:7866 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.331 |
| GRIN2A HGNC:4585 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.327 |
| PDE3B HGNC:8779 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.323 |
| TNNC1 HGNC:11943 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.323 |
| TNNI3 HGNC:11947 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.323 |
| OPCML HGNC:8143 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.323 |
| GHR HGNC:4263 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.322 |
| GSK3B HGNC:4617 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.316 |
| RASGEF1C HGNC:27400 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.312 |
| RAB20 HGNC:18260 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.312 |
| FCHO1 HGNC:29002 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.311 |
| PKDCC HGNC:25123 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.309 |
| NUAK2 HGNC:29558 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.309 |
| IMPA1 HGNC:6050 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.306 |
| AGTPBP1 HGNC:17258 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.306 |
| TRDN HGNC:12261 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.304 |
| GSK3A HGNC:4616 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.303 |
| ALDH1A3 HGNC:409 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.302 |
| PCSK2 HGNC:8744 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.296 |
| KLF7 HGNC:6350 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.295 |
| SUSD2 HGNC:30667 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.293 |
| CREB3L2 HGNC:23720 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.293 |
| NDUFA12 HGNC:23987 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.292 |
| ADGRD1 HGNC:19893 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.292 |
| LUZP2 HGNC:23206 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.288 |
| NPAS3 HGNC:19311 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.287 |
| UST HGNC:17223 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.285 |
| SCFD1 HGNC:20726 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.285 |
| CHRM3 HGNC:1952 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.282 |
| CADM1 HGNC:5951 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.282 |
| ERI3 HGNC:17276 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.279 |
| DPP4 HGNC:3009 | Cystic fibrosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.278 |
| USH2A HGNC:12601 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.278 |
| SCN4A HGNC:10591 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.278 |
| ANKS1B HGNC:24600 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.278 |
| DUSP16 HGNC:17909 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.277 |
| FZD3 HGNC:4041 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.277 |
| ZC3H14 HGNC:20509 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.277 |
| LRP1B HGNC:6693 | Amyotrophic lateral sclerosis | single source observed | automatic checks only | Open Targets Platform | 1 | 0.277 |
| HTR2A HGNC:5293 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.275 |
| DRD3 HGNC:3024 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.274 |
| DRD4 HGNC:3025 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.273 |
| HTR2C HGNC:5295 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.272 |
| SCN8A HGNC:10596 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.271 |
| SCN1A HGNC:10585 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.271 |
| SCN11A HGNC:10583 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.264 |
| MT-ND2 HGNC:7456 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.262 |
| MT-ND6 HGNC:7462 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.262 |
| NDUFV2 HGNC:7717 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.261 |
| NDUFB3 HGNC:7698 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.261 |
| MT-ND1 HGNC:7455 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.261 |
| MT-ND5 HGNC:7461 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.261 |
| MT-ND4 HGNC:7459 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.261 |
| NDUFA3 HGNC:7686 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.261 |
| MT-ND3 HGNC:7458 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.261 |
| NDUFS3 HGNC:7710 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.261 |
| MT-ND4L HGNC:7460 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.261 |
| NDUFA5 HGNC:7688 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.261 |
| NDUFV1 HGNC:7716 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.261 |
| NDUFB8 HGNC:7703 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| NDUFS1 HGNC:7707 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| NDUFAB1 HGNC:7694 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| SCN2A HGNC:10588 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| NDUFA1 HGNC:7683 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| NDUFB1 HGNC:7695 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| NDUFS4 HGNC:7711 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| NDUFA2 HGNC:7685 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| NDUFA6 HGNC:7690 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| COXFA4 HGNC:7687 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| NDUFA7 HGNC:7691 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| NDUFB6 HGNC:7701 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| NDUFA9 HGNC:7693 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| NDUFS7 HGNC:7714 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| NDUFA10 HGNC:7684 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| NDUFA8 HGNC:7692 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| NDUFB5 HGNC:7700 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| NDUFC2 HGNC:7706 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| NDUFS2 HGNC:7708 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| SCN5A HGNC:10593 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| NDUFB2 HGNC:7697 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| NDUFB9 HGNC:7704 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| NDUFC1 HGNC:7705 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| NDUFS6 HGNC:7713 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| NDUFS8 HGNC:7715 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| NDUFV3 HGNC:7719 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| SCN3A HGNC:10590 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.260 |
| GPD2 HGNC:4456 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.259 |
| NDUFA12 HGNC:23987 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.259 |
| NDUFA13 HGNC:17194 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.259 |
| NDUFB10 HGNC:7696 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.259 |
| NDUFB4 HGNC:7699 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.259 |
| NDUFB7 HGNC:7702 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.259 |
| NDUFS5 HGNC:7712 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.259 |
| COXFA4L2 HGNC:29836 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.259 |
| NDUFA11 HGNC:20371 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.259 |
| NDUFAF1 HGNC:18828 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.259 |
| NDUFAF2 HGNC:28086 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.259 |
| NDUFAF3 HGNC:29918 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.259 |
| NDUFAF4 HGNC:21034 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.259 |
| NDUFB11 HGNC:20372 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.259 |
| SCN10A HGNC:10582 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.259 |
| SCN7A HGNC:10594 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.259 |
| SCN9A HGNC:10597 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.259 |
| MSH3 HGNC:7326 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.195 |
| PDE10A HGNC:8772 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.135 |
| PPARGC1A HGNC:9237 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.125 |
| MAPT HGNC:6893 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.125 |
| BDNF HGNC:1033 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.118 |
| CNR1 HGNC:2159 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.116 |
| IL6 HGNC:6018 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.109 |
| TGFB1 HGNC:11766 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.109 |
| SEMA4D HGNC:10732 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.108 |
| NEFL HGNC:7739 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.108 |
| TARDBP HGNC:11571 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.108 |
| HSF1 HGNC:5224 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.107 |
| CRMP1 HGNC:2365 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.106 |
| PRKAB1 HGNC:9378 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.106 |
| GRM5 HGNC:4597 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.105 |
| GRIN3A HGNC:16767 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.104 |
| PRKAA1 HGNC:9376 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.103 |
| ADORA2A HGNC:263 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.102 |
| APOE HGNC:613 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.101 |
| AOPEP HGNC:1361 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.100 |
| DNM1L HGNC:2973 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.100 |
| NGFR HGNC:7809 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.100 |
| UTRN HGNC:12635 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.099 |
| DAPK2 HGNC:2675 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.099 |
| DENR HGNC:2769 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.099 |
| GSK3B HGNC:4617 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.099 |
| YAP1 HGNC:16262 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.099 |
| RPL17 HGNC:10307 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.099 |
| F8A1 HGNC:3547 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.098 |
| F8A2 HGNC:31849 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.098 |
| F8A3 HGNC:31850 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.098 |
| PRKAA2 HGNC:9377 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.098 |
| FOXO3 HGNC:3821 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.098 |
| TGM2 HGNC:11778 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.098 |
| YY1AP1 HGNC:30935 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.098 |
| REST HGNC:9966 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.097 |
| SIRT1 HGNC:14929 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.097 |
| CD8A HGNC:1706 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.096 |
| CASP2 HGNC:1503 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.096 |
| CYP46A1 HGNC:2641 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.096 |
| IGF2 HGNC:5466 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.095 |
| FAN1 HGNC:29170 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.095 |
| ACTB HGNC:132 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.094 |
| PPP1R1B HGNC:9287 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.094 |
| DDIT4 HGNC:24944 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.094 |
| TP53 HGNC:11998 | Huntington disease | single source observed | automatic checks only | Open Targets Platform | 1 | 0.094 |
| No associations match the current filters. | ||||||
Showing 80 of 1440 associations
Releases
One 120-association public preview release per disease, plus a fixed aggregate package for the twelve-disease batch.
Alzheimer disease
alzheimer-top120-v0.1.0-preview
- Status
- 120-association public preview
- Generated
- Jun 14, 2026
- Schema
- 0.1.0
- Latest change
- candidate promotion
Parkinson disease
parkinson-top120-v0.1.0-preview
- Status
- 120-association public preview
- Generated
- Jun 14, 2026
- Schema
- 0.1.0
- Latest change
- candidate promotion
Type 2 diabetes mellitus
type2-diabetes-top120-v0.1.0-preview
- Status
- 120-association public preview
- Generated
- Jun 14, 2026
- Schema
- 0.1.0
- Latest change
- candidate promotion
Breast carcinoma
breast-carcinoma-top120-v0.1.0-preview
- Status
- 120-association public preview
- Generated
- Jun 14, 2026
- Schema
- 0.1.0
- Latest change
- candidate promotion
Dilated cardiomyopathy
dilated-cardiomyopathy-top120-v0.1.0-preview
- Status
- 120-association public preview
- Generated
- Jun 14, 2026
- Schema
- 0.1.0
- Latest change
- candidate promotion
Amyotrophic lateral sclerosis
amyotrophic-lateral-sclerosis-top120-v0.1.0-preview
- Status
- 120-association public preview
- Generated
- Jun 14, 2026
- Schema
- 0.1.0
- Latest change
- candidate promotion
Huntington disease
huntington-disease-top120-v0.1.0-preview
- Status
- 120-association public preview
- Generated
- Jun 14, 2026
- Schema
- 0.1.0
- Latest change
- candidate promotion
Cystic fibrosis
cystic-fibrosis-top120-v0.1.0-preview
- Status
- 120-association public preview
- Generated
- Jun 14, 2026
- Schema
- 0.1.0
- Latest change
- candidate promotion
Schizophrenia
schizophrenia-top120-v0.1.0-preview
- Status
- 120-association public preview
- Generated
- Jun 14, 2026
- Schema
- 0.1.0
- Latest change
- candidate promotion
Epilepsy
epilepsy-top120-v0.1.0-preview
- Status
- 120-association public preview
- Generated
- Jun 14, 2026
- Schema
- 0.1.0
- Latest change
- candidate promotion
Inflammatory bowel disease
inflammatory-bowel-disease-top120-v0.1.0-preview
- Status
- 120-association public preview
- Generated
- Jun 14, 2026
- Schema
- 0.1.0
- Latest change
- candidate promotion
Hypertrophic cardiomyopathy
hypertrophic-cardiomyopathy-top120-v0.1.0-preview
- Status
- 120-association public preview
- Generated
- Jun 14, 2026
- Schema
- 0.1.0
- Latest change
- candidate promotion
What This Preview Shows
The page is intentionally narrow: it renders fixed 120-association public preview artifacts, keeps source rows traceable, and separates observed source evidence from scientific certainty. The current preview uses release genes checked against authority snapshots and keeps fixture-derived evidence out of public claims.
Release Gate
The twelve-disease public preview aggregate has passed the current release gate sequence: source review, freshness acknowledgement, source silence/disagreement rollup, sampled human review, error taxonomy, advisory referee review, clinical-language boundary scan, and archive checksum verification. Those gates make the package traceable and fixed; they do not make it clinical guidance.
Sources, Licenses, And Use Boundaries
Source names identify provenance only. They do not imply endorsement, clinical validity, or completeness across biomedical knowledge.
This released data package is licensed under CC BY 4.0 (attribution required, redistribution permitted, no endorsement implied); CC BY 4.0 is the floor set by MONDO. Per-source upstream terms are below and in the package LICENSE.
HGNC
- License
- CC0 1.0
- Terms
- source terms
- Accessed
- Jun 14, 2026
- Freshness
- refresh recommended
Source freshness: refresh recommended; assessed Jun 9, 2026. Acceptable for public-candidate rendering; re-check HGNC citation and license pages before formal reuse. Next review: Jul 9, 2026.
HGNC data are used for stable gene symbol and identifier normalization.
Citation: Genenames.org: the HGNC and PGNC resources in 2026, Nucleic Acids Research, 2025 , DOI 10.1093/nar/gkaf1229 , PMID 41287213 .
- HGNC states that all HGNC data are freely available under Creative Commons Zero.
- HGNC recommends attribution even though source attribution is not mandatory under CC0.
MONDO Disease Ontology
- License
- CC BY 4.0
- Terms
- source terms
- Accessed
- Jun 7, 2026
- Freshness
- refresh recommended
Source freshness: refresh recommended; assessed Jun 9, 2026. Acceptable as disease identifier context for public-candidate rendering; re-check MONDO license and citation metadata before formal reuse. Next review: Jul 9, 2026.
MONDO is used for disease identifiers and disease label context.
Citation: Mondo: integrating disease terminology across communities, Genetics, 2025 , DOI 10.1093/genetics/iyaf215 .
- Mondo source metadata must be re-checked before release promotion.
Open Targets Platform
- License
- CC0 1.0
- Terms
- source terms
- Accessed
- Jun 14, 2026
- Freshness
- refresh recommended
Source freshness: refresh recommended; assessed Jun 9, 2026. Acceptable for public-candidate rendering; re-check Open Targets license, terms, and citation pages before formal reuse. Next review: Jul 9, 2026.
Snapshot freshness: refresh recommended; assessed Jun 9, 2026. The fixed Open Targets development snapshot is acceptable for public-candidate rendering, but formal reuse should refresh from a dated upstream export or documented current source pull. Next review: Jul 9, 2026. Snapshot api-v4-graphql-2026-06-14-paper120, 120 records, accessed Jun 14, 2026.
Snapshot freshness: refresh recommended; assessed Jun 9, 2026. The fixed Open Targets development snapshot is acceptable for public-candidate rendering, but formal reuse should refresh from a dated upstream export or documented current source pull. Next review: Jul 9, 2026. Snapshot api-v4-graphql-2026-06-14-paper120, 120 records, accessed Jun 14, 2026.
Snapshot freshness: refresh recommended; assessed Jun 9, 2026. The fixed Open Targets development snapshot is acceptable for public-candidate rendering, but formal reuse should refresh from a dated upstream export or documented current source pull. Next review: Jul 9, 2026. Snapshot api-v4-graphql-2026-06-14-paper120, 120 records, accessed Jun 14, 2026.
Snapshot freshness: refresh recommended; assessed Jun 9, 2026. The fixed Open Targets development snapshot is acceptable for public-candidate rendering, but formal reuse should refresh from a dated upstream export or documented current source pull. Next review: Jul 9, 2026. Snapshot api-v4-graphql-2026-06-14-paper120, 120 records, accessed Jun 14, 2026.
Snapshot freshness: refresh recommended; assessed Jun 9, 2026. The fixed Open Targets development snapshot is acceptable for public-candidate rendering, but formal reuse should refresh from a dated upstream export or documented current source pull. Next review: Jul 9, 2026. Snapshot api-v4-graphql-2026-06-14-paper120, 120 records, accessed Jun 14, 2026.
Snapshot freshness: refresh recommended; assessed Jun 9, 2026. The fixed Open Targets development snapshot is acceptable for public-candidate rendering, but formal reuse should refresh from a dated upstream export or documented current source pull. Next review: Jul 9, 2026. Snapshot api-v4-graphql-2026-06-14-paper120, 120 records, accessed Jun 14, 2026.
Snapshot freshness: refresh recommended; assessed Jun 9, 2026. The fixed Open Targets development snapshot is acceptable for public-candidate rendering, but formal reuse should refresh from a dated upstream export or documented current source pull. Next review: Jul 9, 2026. Snapshot api-v4-graphql-2026-06-14-paper120, 120 records, accessed Jun 14, 2026.
Snapshot freshness: refresh recommended; assessed Jun 9, 2026. The fixed Open Targets development snapshot is acceptable for public-candidate rendering, but formal reuse should refresh from a dated upstream export or documented current source pull. Next review: Jul 9, 2026. Snapshot api-v4-graphql-2026-06-14-paper120, 120 records, accessed Jun 14, 2026.
Snapshot freshness: refresh recommended; assessed Jun 9, 2026. The fixed Open Targets development snapshot is acceptable for public-candidate rendering, but formal reuse should refresh from a dated upstream export or documented current source pull. Next review: Jul 9, 2026. Snapshot api-v4-graphql-2026-06-14-paper120, 120 records, accessed Jun 14, 2026.
Snapshot freshness: refresh recommended; assessed Jun 9, 2026. The fixed Open Targets development snapshot is acceptable for public-candidate rendering, but formal reuse should refresh from a dated upstream export or documented current source pull. Next review: Jul 9, 2026. Snapshot api-v4-graphql-2026-06-14-paper120, 120 records, accessed Jun 14, 2026.
Snapshot freshness: refresh recommended; assessed Jun 9, 2026. The fixed Open Targets development snapshot is acceptable for public-candidate rendering, but formal reuse should refresh from a dated upstream export or documented current source pull. Next review: Jul 9, 2026. Snapshot api-v4-graphql-2026-06-14-paper120, 120 records, accessed Jun 14, 2026.
Snapshot freshness: refresh recommended; assessed Jun 9, 2026. The fixed Open Targets development snapshot is acceptable for public-candidate rendering, but formal reuse should refresh from a dated upstream export or documented current source pull. Next review: Jul 9, 2026. Snapshot api-v4-graphql-2026-06-14-paper120, 120 records, accessed Jun 14, 2026.
Open Targets Platform data are used as source-attributed target-disease association evidence.
Citation: Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research, 2025 , DOI 10.1093/nar/gkae1128 .
- Open Targets Platform data is marked CC0 1.0 in the official licence documentation.
- Open Targets expects attribution for online services, databases, or software according to good scientific practice.
ClinVar
- Terms
- source terms
- Accessed
- Jun 14, 2026
- Freshness
- refresh recommended
Source freshness: refresh recommended; assessed Jun 9, 2026. Acceptable for public-candidate rendering; re-check NCBI/ClinVar attribution and reuse guidance before formal reuse. Next review: Jul 9, 2026.
Snapshot freshness: refresh recommended; assessed Jun 9, 2026. The fixed ClinVar gene-condition snapshot is acceptable for public-candidate rendering, but formal reuse should prefer an archived monthly ClinVar release or otherwise documented dated upstream material. Next review: Jul 9, 2026. Snapshot gene_condition_source_id-2026-06-14-paper120, 6 records, accessed Jun 14, 2026.
Snapshot freshness: refresh recommended; assessed Jun 9, 2026. The fixed ClinVar gene-condition snapshot is acceptable for public-candidate rendering, but formal reuse should prefer an archived monthly ClinVar release or otherwise documented dated upstream material. Next review: Jul 9, 2026. Snapshot gene_condition_source_id-2026-06-14-paper120, 12 records, accessed Jun 14, 2026.
Snapshot freshness: refresh recommended; assessed Jun 9, 2026. The fixed ClinVar gene-condition snapshot is acceptable for public-candidate rendering, but formal reuse should prefer an archived monthly ClinVar release or otherwise documented dated upstream material. Next review: Jul 9, 2026. Snapshot gene_condition_source_id-2026-06-14-paper120, 21 records, accessed Jun 14, 2026.
Snapshot freshness: refresh recommended; assessed Jun 9, 2026. The fixed ClinVar gene-condition snapshot is acceptable for public-candidate rendering, but formal reuse should prefer an archived monthly ClinVar release or otherwise documented dated upstream material. Next review: Jul 9, 2026. Snapshot gene_condition_source_id-2026-06-14-paper120, 0 records, accessed Jun 14, 2026.
Snapshot freshness: refresh recommended; assessed Jun 9, 2026. The fixed ClinVar gene-condition snapshot is acceptable for public-candidate rendering, but formal reuse should prefer an archived monthly ClinVar release or otherwise documented dated upstream material. Next review: Jul 9, 2026. Snapshot gene_condition_source_id-2026-06-14-paper120, 0 records, accessed Jun 14, 2026.
Snapshot freshness: refresh recommended; assessed Jun 9, 2026. The fixed ClinVar gene-condition snapshot is acceptable for public-candidate rendering, but formal reuse should prefer an archived monthly ClinVar release or otherwise documented dated upstream material. Next review: Jul 9, 2026. Snapshot gene_condition_source_id-2026-06-14-paper120, 17 records, accessed Jun 14, 2026.
Snapshot freshness: refresh recommended; assessed Jun 9, 2026. The fixed ClinVar gene-condition snapshot is acceptable for public-candidate rendering, but formal reuse should prefer an archived monthly ClinVar release or otherwise documented dated upstream material. Next review: Jul 9, 2026. Snapshot gene_condition_source_id-2026-06-14-paper120, 1 record, accessed Jun 14, 2026.
Snapshot freshness: refresh recommended; assessed Jun 9, 2026. The fixed ClinVar gene-condition snapshot is acceptable for public-candidate rendering, but formal reuse should prefer an archived monthly ClinVar release or otherwise documented dated upstream material. Next review: Jul 9, 2026. Snapshot gene_condition_source_id-2026-06-14-paper120, 2 records, accessed Jun 14, 2026.
Snapshot freshness: refresh recommended; assessed Jun 9, 2026. The fixed ClinVar gene-condition snapshot is acceptable for public-candidate rendering, but formal reuse should prefer an archived monthly ClinVar release or otherwise documented dated upstream material. Next review: Jul 9, 2026. Snapshot gene_condition_source_id-2026-06-14-paper120, 6 records, accessed Jun 14, 2026.
Snapshot freshness: refresh recommended; assessed Jun 9, 2026. The fixed ClinVar gene-condition snapshot is acceptable for public-candidate rendering, but formal reuse should prefer an archived monthly ClinVar release or otherwise documented dated upstream material. Next review: Jul 9, 2026. Snapshot gene_condition_source_id-2026-06-14-paper120, 0 records, accessed Jun 14, 2026.
Snapshot freshness: refresh recommended; assessed Jun 9, 2026. The fixed ClinVar gene-condition snapshot is acceptable for public-candidate rendering, but formal reuse should prefer an archived monthly ClinVar release or otherwise documented dated upstream material. Next review: Jul 9, 2026. Snapshot gene_condition_source_id-2026-06-14-paper120, 0 records, accessed Jun 14, 2026.
Snapshot freshness: refresh recommended; assessed Jun 9, 2026. The fixed ClinVar gene-condition snapshot is acceptable for public-candidate rendering, but formal reuse should prefer an archived monthly ClinVar release or otherwise documented dated upstream material. Next review: Jul 9, 2026. Snapshot gene_condition_source_id-2026-06-14-paper120, 0 records, accessed Jun 14, 2026.
ClinVar gene-condition context is used as source-attributed evidence, not as clinical certainty.
Citation: ClinVar: improving access to variant interpretations and supporting evidence, Nucleic Acids Research, 2018 , DOI 10.1093/nar/gkx1153 , PMID 29165669 , PMCID PMC5753237.
- ClinVar asks that distributed or copied data attribute ClinVar as a data source.
- ClinVar content is not direct diagnostic or medical decision-making guidance.
Experimental Factor Ontology
- License
- Apache License 2.0
- Terms
- source terms
- Accessed
- Jun 11, 2026
- Freshness
- refresh recommended
Source freshness: refresh recommended; assessed Jun 11, 2026. Acceptable as originating ontology context for public-candidate rendering; re-check EFO license and citation metadata before formal reuse. Next review: Jul 11, 2026.
EFO is used as source-attributed originating ontology context for Open Targets disease nodes that are crosswalked to canonical MONDO disease ids.
Citation: Modeling sample variables with an Experimental Factor Ontology, Bioinformatics, 2010 , DOI 10.1093/bioinformatics/btq099 , PMID 20200009 , PMCID PMC2853691.
- EFO is developed by EMBL-EBI and is used by Open Targets for disease nodes.
- EFO provenance is rendered as ontology/crosswalk context, not as gene-disease evidence.
MONDO is used for disease identifier and label context under CC BY 4.0. Open Targets scores are rendered as source-attributed evidence signals, not as truth, clinical validity, or a combined confidence score. ClinVar records are shown as variant/condition source context and must not be used for diagnosis, treatment guidance, patient risk prediction, or clinical decision support. See the methods and glossary page for release labels and review boundaries.